Top American Well Executives Quietly Unload Shares in Notable Insider Moves

New insider activity at American Well ( (AMWL) ) has taken place on January 5, 2026.Claim 70% Off TipRanks This Holiday SeasonUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential American Well insiders have been trimming their holdings, with Intl. President Phyllis Gotlib selling 3,707 shares of company stock in a transaction worth $17,978, while Chief Product & Technology Officer Dmitry Zamansky offloaded 6,243 shares for $30,278. These back-to-back insider sales highlight notable executive activity in American Well’s leadership ranks. Recent Updates on AMWL stock Over the last 24 hours, American Well (Amwell) has been in focus due to both a major contract extension and a downward revision in analyst expectations. The company announced that it has amended and extended its long-term agreement with Elevance Health for operating the LiveHealth Online digital care platform, securing subscription and related services revenue visibility from January 2026 through at least January 2029, with automatic renewals thereafter. This reinforces the stability of its core telehealth partnership and ensures continued access to a nationwide clinician network via its clinical partner, Online Care Group. At the same time, Morgan Stanley reduced its price target on Amwell, citing a broader 2026 sector view in which healthcare technology and providers present alpha-generation opportunities but are set against a challenging environment, particularly for managed care, with ongoing policy, reimbursement, and utilization headwinds. Additional AI-driven and analyst commentary underscores that Amwell’s weak financial profile—declining revenues, persistent losses, bearish technicals, and unattractive valuation due to negative earnings—continues to temper optimism from cost-cutting efforts and subscription revenue growth, contributing to a more cautious stance on the stock despite the renewed Elevance contract. Recent trading sentiment and technical signals remain negative, reflecting these mixed fundamentals and sector pressures rather than any single company-specific event. Spark’s Take on AMWL Stock According to Spark, TipRanks’ AI Analyst, AMWL is a Neutral. The score is held back primarily by weak financial performance (large ongoing losses and negative free cash flow) and a loss-making valuation profile (negative P/E, no dividend). These are partially offset by improving earnings-call trends (better margins, lower opex, improved EBITDA guidance), a low-leverage balance sheet, and moderately improving near-term technical momentum, with incremental support from the extended Elevance partnership. To see Spark’s full report on AMWL stock, click here. More about American Well YTD Price Performance: -1.22% Average Trading Volume: 120,578 Technical Sentiment Signal: Sell Current Market Cap: $79.4M